Prior Authorization, a Deductible, and Two Days Until the Flight
A 45-year-old woman with commercial insurance (not Medicare or Medicaid) presents a new prescription for sumatriptan/naproxen 85/500 mg tablets, quantity 9, from her neurologist. The claim rejects: prior authorization required, code 75. Your contracted reimbursement for this NDC is AWP minus 18% plus a $2.00 dispensing fee; AWP for 9 tablets is $450.00. Her plan has $500 of deductible remaining, then 20% coinsurance, and the brand sits on tier 3. Two tier-1 generics - sumatriptan 50 mg tablets and naproxen 500 mg tablets - need no PA and each carry a $10 copay. The prescriber's office says a PA takes 3 to 5 business days, and she leaves on a trip in 2 days with 2 tablets left. She asks whether she should just run it through a discount card and whether the pharmacy can eat the cost.
1. Calculate what she would pay under each path. Show the math.
Read the worked answer
Path 1 - brand, if the PA were approved today
- Contracted price: $450.00 x 0.82 = $369.00, plus $2.00 dispensing fee = $371.00
- Her deductible remaining is $500, which is more than $371. Under a deductible, she pays the full allowed amount until the deductible is satisfied - coinsurance does not start yet.
- So even with an approved PA, she pays $371.00 today, and $371 of her $500 deductible is consumed.
- Only after the deductible is exhausted would the 20% apply: 20% of $371 would have been about $74.20.
Path 2 - tier-1 generics
- $10 copay for sumatriptan plus $10 copay for naproxen = $20.00 total. No PA, no deductible issue.
- Caveat: this requires a new prescription. Two separate generic ingredients are not a same-drug substitution for a combination product, so you cannot convert it yourself.
Path 3 - discount card / cash
- Whatever the card quotes is a cash transaction. It is not billed to her plan, does not count toward her deductible, and cannot be combined with an insurance claim for the same fill.
- Compare it honestly against $371 before recommending it. It may well be cheaper, but the deductible consequence is real and she should hear it from you.
The point to make to her The prior authorization is not the thing standing between her and relief - her deductible is. Even a fast PA leaves her paying $371, while a prescriber-authorized generic switch costs $20 and fits in her carry-on today.
2. What is your plan to get her something before her trip, and what are you not allowed to do?
Read the worked answer
Plan
- Call the prescriber's office now, while she is at the counter, and frame it as a concrete request: "Patient travels in 2 days. The brand requires a PA and her remaining deductible makes it $371. Would you authorize sumatriptan 50 mg plus naproxen 500 mg as separate prescriptions?" Offer to send the rejection and the price comparison.
- If the neurologist wants the combination product for a clinical reason (for example, she has failed the components separately), then start the PA in parallel - ask the office what documentation the plan requires and offer the fill history.
- Give her a realistic timeline in writing and a way to reach you, since she will be traveling.
What you cannot do
- You cannot substitute a different drug or dosage form on your own authority. Generic substitution laws cover therapeutically equivalent products, not a switch from a combination tablet to two separate generics.
- You cannot bill the plan and also collect a discount-card or cash price for the same dispense.
- You cannot routinely waive her cost-sharing. That breaches her plan agreement and creates anti-kickback exposure unless a documented financial hardship policy applies to all patients equally.
- You cannot dispense against the PA denial and "sort it out later." The claim will not pay, and you have given away inventory with no reimbursement.
Why this is the right call The cheapest clinically equivalent option is also the fastest one. You are not pushing her off the prescribed therapy - you are asking the prescriber to choose between two clinically reasonable plans with very different patient costs.
3. She asks whether the pharmacy can just bill it now and fix the PA afterward. What do you say, and how do you document it?
Read the worked answer
What you tell her
- No, and the reason is not bureaucratic. Until the plan approves it, the claim is unpaid. Dispensing now means the pharmacy has handed over a $371 product with no established payer, and the fix later is not a fix - reversing and rebilling a claim to a different payer after the fact, or billing a claim you know will deny, both misrepresent what happened.
- What you can do is dispense it as a documented cash sale if she chooses that, with the price stated up front, and tell her exactly what she is giving up: no deductible credit, no out-of-pocket maximum credit, and no later insurance reimbursement on a PA-required item.
- Then immediately offer the $20 alternative and let her decide. A patient who understands the numbers usually chooses the cheaper path without any pressure from you.
Documentation
- The rejection code and date, and that the PA requirement was communicated to the prescriber's office, with name and time.
- The price quoted to the patient for each path, and which one she chose.
- That she was told a cash fill does not accrue to her deductible.
- A note that the generic-switch request is pending with the prescriber, with a follow-up date, so the next shift knows the conversation is live.
The judgment principle Report what happened accurately even when accuracy costs a sale. The billing error you commit to move one prescription along is the same error that gets clawed back in an audit a year later - and by then the pharmacist's name is on it.